Capital Guardian Trust’s AstraZeneca AZN Stock Holding History

Capital Guardian Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$60.6M	Buy	738,917 +320,944	+77%	+$25.2M	0.82%	43
2019 Q1	$35.7M	Sell	417,973 -461,975	-53%	-$36.4M	0.47%	87
2018 Q4	$66.8M	Buy	879,948 +52,128	+6%	+$4.07M	1.06%	28
2018 Q3	$65.5M	Buy	827,820 +53,424	+7%	+$4.04M	0.88%	38
2018 Q2	$54.4M	Buy	774,396 +57,675	+8%	+$4.15M	0.77%	53
2018 Q1	$50.1M	Buy	716,721 +109,530	+18%	+$7.59M	0.71%	59
2017 Q4	$42.1M	Buy	607,191 +553,431	+1,029%	+$37.3M	0.6%	66
2017 Q3	$3.64M	Sell	53,760 -35,940	-40%	-$2.27M	0.06%	143
2017 Q2	$6.12M	Sell	89,700 -1,472,463	-94%	-$96.2M	0.11%	134
2017 Q1	$97.3M	Buy	1,562,163 +295,380	+23%	+$17.2M	0.73%	52
2016 Q4	$69.2M	Sell	1,266,783 -76,899	-6%	-$4.37M	0.54%	72
2016 Q3	$88.3M	Buy	1,343,682 +72,272	+6%	+$4.72M	0.67%	56
2016 Q2	$76.8M	Buy	1,271,410 +21,401	+2%	+$1.24M	0.59%	63
2016 Q1	$70.4M	Buy	1,250,009 +155,629	+14%	+$9.35M	0.54%	74
2015 Q4	$74.3M	Buy	1,094,380 +201,976	+23%	+$13.2M	0.58%	60
2015 Q3	$56.8M	Buy	892,404 +172,215	+24%	+$11.3M	0.46%	83
2015 Q2	$45.9M	Buy	720,189 +116,054	+19%	+$7.95M	0.33%	105
2015 Q1	$41.3M	Buy	604,135 +207,171	+52%	+$14.4M	0.31%	105
2014 Q4	$27.9M	Buy	396,964 +163,406	+70%	+$11.7M	0.19%	121
2014 Q3	$16.7M	Buy	233,558 +232,458	+21,133%	+$17M	0.12%	144
2014 Q2	$82K	Hold	1,100	–	–	﹤0.01%	355
2014 Q1	$71K	Sell	1,100 -95	-8%	-$6.13K	﹤0.01%	360
2013 Q4	$71K	Buy	1,195 +95	+9%	+$5.16K	﹤0.01%	351
2013 Q3	$57K	Hold	1,100	–	–	﹤0.01%	334
2013 Q2	$52K	Buy	+1,100	New	+$56K	﹤0.01%	323

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Capital Guardian Trust's AZN Position: Q2 2019 in Review

Capital Guardian Trust increased its AstraZeneca (AZN) stake by 77% in Q2 2019, buying an estimated $25.2M and bringing the position to 738,917 shares worth $60.6M. The position accounts for 0.82% of the portfolio, ranked #43.

Capital Guardian Trust first reported a position in AZN in Q2 2013 and has held it in 25 quarters since. The position peaked at $97.3M in Q1 2017. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

Capital Guardian Trust held 738,917 shares of AstraZeneca worth $60.6M as of Q2 2019.
Capital Guardian Trust bought 320,944 AstraZeneca shares in Q2 2019, an estimated $25.2M.
AstraZeneca made up 0.82% of Capital Guardian Trust's portfolio in Q2 2019, its #43 holding.
Capital Guardian Trust first reported a position in AstraZeneca in Q2 2013 and has held it in 25 quarters since.
Capital Guardian Trust's AstraZeneca position peaked at $97.3M in Q1 2017.
546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.